ID	Gene Name	Species	GOTERM_BP_DIRECT	GOTERM_CC_DIRECT	GOTERM_MF_DIRECT	KEGG_PATHWAY	OMIM_DISEASE	REACTOME_PATHWAY
CCL23	C-C motif chemokine ligand 23(CCL23)	Homo sapiens	GO:0002548~monocyte chemotaxis,GO:0006874~cellular calcium ion homeostasis,GO:0006935~chemotaxis,GO:0006954~inflammatory response,GO:0006955~immune response,GO:0007165~signal transduction,GO:0007186~G-protein coupled receptor signaling pathway,GO:0007267~cell-cell signaling,GO:0008285~negative regulation of cell proliferation,GO:0030593~neutrophil chemotaxis,GO:0043547~positive regulation of GTPase activity,GO:0048247~lymphocyte chemotaxis,GO:0050729~positive regulation of inflammatory response,GO:0070098~chemokine-mediated signaling pathway,GO:0070374~positive regulation of ERK1 and ERK2 cascade,GO:0071346~cellular response to interferon-gamma,GO:0071347~cellular response to interleukin-1,GO:0071356~cellular response to tumor necrosis factor,GO:2001264~negative regulation of C-C chemokine binding,	GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0005623~cell,	GO:0008009~chemokine activity,GO:0008201~heparin binding,GO:0031726~CCR1 chemokine receptor binding,	hsa04060:Cytokine-cytokine receptor interaction,hsa04062:Chemokine signaling pathway,		R-HSA-416476:R-HSA-416476,R-HSA-418594:R-HSA-418594,R-HSA-444473:R-HSA-444473,
CCL3	C-C motif chemokine ligand 3(CCL3)	Homo sapiens	GO:0000165~MAPK cascade,GO:0001649~osteoblast differentiation,GO:0001775~cell activation,GO:0002548~monocyte chemotaxis,GO:0006816~calcium ion transport,GO:0006874~cellular calcium ion homeostasis,GO:0006887~exocytosis,GO:0006935~chemotaxis,GO:0006954~inflammatory response,GO:0006955~immune response,GO:0007010~cytoskeleton organization,GO:0007186~G-protein coupled receptor signaling pathway,GO:0007267~cell-cell signaling,GO:0007610~behavior,GO:0008360~regulation of cell shape,GO:0009636~response to toxic substance,GO:0010628~positive regulation of gene expression,GO:0010629~negative regulation of gene expression,GO:0010818~T cell chemotaxis,GO:0014808~release of sequestered calcium ion into cytosol by sarcoplasmic reticulum,GO:0019722~calcium-mediated signaling,GO:0023052~signaling,GO:0030335~positive regulation of cell migration,GO:0030502~negative regulation of bone mineralization,GO:0030593~neutrophil chemotaxis,GO:0031663~lipopolysaccharide-mediated signaling pathway,GO:0032760~positive regulation of tumor necrosis factor production,GO:0043308~eosinophil degranulation,GO:0043491~protein kinase B signaling,GO:0043525~positive regulation of neuron apoptotic process,GO:0043547~positive regulation of GTPase activity,GO:0043615~astrocyte cell migration,GO:0043922~negative regulation by host of viral transcription,GO:0045671~negative regulation of osteoclast differentiation,GO:0048245~eosinophil chemotaxis,GO:0048246~macrophage chemotaxis,GO:0048247~lymphocyte chemotaxis,GO:0050718~positive regulation of interleukin-1 beta secretion,GO:0050729~positive regulation of inflammatory response,GO:0050850~positive regulation of calcium-mediated signaling,GO:0050918~positive chemotaxis,GO:0051897~positive regulation of protein kinase B signaling,GO:0051928~positive regulation of calcium ion transport,GO:0051930~regulation of sensory perception of pain,GO:0060326~cell chemotaxis,GO:0070098~chemokine-mediated signaling pathway,GO:0070374~positive regulation of ERK1 and ERK2 cascade,GO:0070723~response to cholesterol,GO:0071346~cellular response to interferon-gamma,GO:0071347~cellular response to interleukin-1,GO:0071356~cellular response to tumor necrosis factor,GO:0071407~cellular response to organic cyclic compound,GO:0071621~granulocyte chemotaxis,GO:0090280~positive regulation of calcium ion import,GO:2000503~positive regulation of natural killer cell chemotaxis,	GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0005622~intracellular,GO:0005737~cytoplasm,GO:0005829~cytosol,	GO:0004672~protein kinase activity,GO:0004698~calcium-dependent protein kinase C activity,GO:0005515~protein binding,GO:0008009~chemokine activity,GO:0016004~phospholipase activator activity,GO:0016301~kinase activity,GO:0031726~CCR1 chemokine receptor binding,GO:0031730~CCR5 chemokine receptor binding,GO:0042056~chemoattractant activity,GO:0042802~identical protein binding,	hsa04060:Cytokine-cytokine receptor interaction,hsa04062:Chemokine signaling pathway,hsa04620:Toll-like receptor signaling pathway,hsa05132:Salmonella infection,hsa05142:Chagas disease (American trypanosomiasis),hsa05323:Rheumatoid arthritis,	609423~HIV infection, resistance to,	R-HSA-380108:R-HSA-380108,
CCL4	C-C motif chemokine ligand 4(CCL4)	Homo sapiens	GO:0002548~monocyte chemotaxis,GO:0006928~movement of cell or subcellular component,GO:0006954~inflammatory response,GO:0006955~immune response,GO:0007155~cell adhesion,GO:0007163~establishment or maintenance of cell polarity,GO:0007165~signal transduction,GO:0007186~G-protein coupled receptor signaling pathway,GO:0007267~cell-cell signaling,GO:0009615~response to virus,GO:0009636~response to toxic substance,GO:0030593~neutrophil chemotaxis,GO:0035690~cellular response to drug,GO:0043547~positive regulation of GTPase activity,GO:0043922~negative regulation by host of viral transcription,GO:0050729~positive regulation of inflammatory response,GO:0050850~positive regulation of calcium-mediated signaling,GO:0051928~positive regulation of calcium ion transport,GO:0070098~chemokine-mediated signaling pathway,GO:0070374~positive regulation of ERK1 and ERK2 cascade,GO:0071346~cellular response to interferon-gamma,GO:0071347~cellular response to interleukin-1,GO:0071356~cellular response to tumor necrosis factor,GO:2000503~positive regulation of natural killer cell chemotaxis,	GO:0005576~extracellular region,GO:0005615~extracellular space,	GO:0005125~cytokine activity,GO:0005515~protein binding,GO:0008009~chemokine activity,GO:0031726~CCR1 chemokine receptor binding,GO:0031730~CCR5 chemokine receptor binding,GO:0042802~identical protein binding,	hsa04060:Cytokine-cytokine receptor interaction,hsa04062:Chemokine signaling pathway,hsa04064:NF-kappa B signaling pathway,hsa04620:Toll-like receptor signaling pathway,hsa04623:Cytosolic DNA-sensing pathway,hsa05132:Salmonella infection,		R-HSA-380108:R-HSA-380108,
CCL7	C-C motif chemokine ligand 7(CCL7)	Homo sapiens	GO:0002548~monocyte chemotaxis,GO:0006874~cellular calcium ion homeostasis,GO:0006935~chemotaxis,GO:0006954~inflammatory response,GO:0007010~cytoskeleton organization,GO:0007165~signal transduction,GO:0007186~G-protein coupled receptor signaling pathway,GO:0007267~cell-cell signaling,GO:0008360~regulation of cell shape,GO:0010332~response to gamma radiation,GO:0030335~positive regulation of cell migration,GO:0030593~neutrophil chemotaxis,GO:0043547~positive regulation of GTPase activity,GO:0048245~eosinophil chemotaxis,GO:0050729~positive regulation of inflammatory response,GO:0070098~chemokine-mediated signaling pathway,GO:0070374~positive regulation of ERK1 and ERK2 cascade,GO:0071346~cellular response to interferon-gamma,GO:0071347~cellular response to interleukin-1,GO:0071356~cellular response to tumor necrosis factor,GO:0071361~cellular response to ethanol,GO:2000503~positive regulation of natural killer cell chemotaxis,	GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0005623~cell,	GO:0005515~protein binding,GO:0008009~chemokine activity,GO:0008201~heparin binding,GO:0031726~CCR1 chemokine receptor binding,GO:0031727~CCR2 chemokine receptor binding,	hsa04060:Cytokine-cytokine receptor interaction,hsa04062:Chemokine signaling pathway,		R-HSA-380108:R-HSA-380108,
CCL8	C-C motif chemokine ligand 8(CCL8)	Homo sapiens	GO:0002548~monocyte chemotaxis,GO:0002687~positive regulation of leukocyte migration,GO:0006468~protein phosphorylation,GO:0006816~calcium ion transport,GO:0006874~cellular calcium ion homeostasis,GO:0006887~exocytosis,GO:0006935~chemotaxis,GO:0006954~inflammatory response,GO:0006955~immune response,GO:0007165~signal transduction,GO:0007186~G-protein coupled receptor signaling pathway,GO:0007267~cell-cell signaling,GO:0009615~response to virus,GO:0030593~neutrophil chemotaxis,GO:0043547~positive regulation of GTPase activity,GO:0048247~lymphocyte chemotaxis,GO:0050729~positive regulation of inflammatory response,GO:0060326~cell chemotaxis,GO:0070098~chemokine-mediated signaling pathway,GO:0070374~positive regulation of ERK1 and ERK2 cascade,GO:0070664~negative regulation of leukocyte proliferation,GO:0071346~cellular response to interferon-gamma,GO:0071347~cellular response to interleukin-1,GO:0071356~cellular response to tumor necrosis factor,	GO:0005615~extracellular space,GO:0005623~cell,	GO:0004672~protein kinase activity,GO:0008009~chemokine activity,GO:0008201~heparin binding,GO:0016004~phospholipase activator activity,GO:0048020~CCR chemokine receptor binding,	hsa04060:Cytokine-cytokine receptor interaction,hsa04062:Chemokine signaling pathway,
CXCL1	C-X-C motif chemokine ligand 1(CXCL1)	Homo sapiens	GO:0006935~chemotaxis,GO:0006954~inflammatory response,GO:0006955~immune response,GO:0007165~signal transduction,GO:0007186~G-protein coupled receptor signaling pathway,GO:0007399~nervous system development,GO:0008283~cell proliferation,GO:0008285~negative regulation of cell proliferation,GO:0030036~actin cytoskeleton organization,GO:0032496~response to lipopolysaccharide,GO:0035556~intracellular signal transduction,GO:0043085~positive regulation of catalytic activity,GO:0060326~cell chemotaxis,GO:0070098~chemokine-mediated signaling pathway,GO:0090023~positive regulation of neutrophil chemotaxis,	GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0005622~intracellular,	GO:0005102~receptor binding,GO:0008009~chemokine activity,GO:0008047~enzyme activator activity,GO:0008083~growth factor activity,GO:0045236~CXCR chemokine receptor binding,	hsa04060:Cytokine-cytokine receptor interaction,hsa04062:Chemokine signaling pathway,hsa04621:NOD-like receptor signaling pathway,hsa04668:TNF signaling pathway,hsa05132:Salmonella infection,hsa05134:Legionellosis,		R-HSA-380108:R-HSA-380108,R-HSA-418594:R-HSA-418594,
CD244	CD244 molecule(CD244)	Homo sapiens	GO:0001773~myeloid dendritic cell activation,GO:0002250~adaptive immune response,GO:0002323~natural killer cell activation involved in immune response,GO:0007165~signal transduction,GO:0032819~positive regulation of natural killer cell proliferation,GO:0045087~innate immune response,GO:0050900~leukocyte migration,GO:0060732~positive regulation of inositol phosphate biosynthetic process,GO:0071663~positive regulation of granzyme B production,GO:1902715~positive regulation of interferon-gamma secretion,GO:2000484~positive regulation of interleukin-8 secretion,GO:2000566~positive regulation of CD8-positive, alpha-beta T cell proliferation,	GO:0005886~plasma membrane,GO:0009897~external side of plasma membrane,GO:0016021~integral component of membrane,	GO:0004872~receptor activity,GO:0005515~protein binding,GO:0042288~MHC class I protein binding,	hsa04650:Natural killer cell mediated cytotoxicity,	180300~Rheumatoid arthritis, susceptibility to,	R-HSA-202733:R-HSA-202733,
CD274	CD274 molecule(CD274)	Homo sapiens	GO:0006955~immune response,GO:0007165~signal transduction,GO:0007166~cell surface receptor signaling pathway,GO:0030335~positive regulation of cell migration,GO:0031295~T cell costimulation,GO:0032689~negative regulation of interferon-gamma production,GO:0032693~negative regulation of interleukin-10 production,GO:0034097~response to cytokine,GO:0042102~positive regulation of T cell proliferation,GO:0046006~regulation of activated T cell proliferation,GO:0046007~negative regulation of activated T cell proliferation,GO:0070232~regulation of T cell apoptotic process,GO:1901998~toxin transport,GO:1903556~negative regulation of tumor necrosis factor superfamily cytokine production,GO:2001181~positive regulation of interleukin-10 secretion,	GO:0005886~plasma membrane,GO:0009897~external side of plasma membrane,GO:0012505~endomembrane system,GO:0016021~integral component of membrane,GO:0070062~extracellular exosome,	GO:0005515~protein binding,	hsa04514:Cell adhesion molecules (CAMs),		R-HSA-389948:R-HSA-389948,
CD40	CD40 molecule(CD40)	Homo sapiens	GO:0001934~positive regulation of protein phosphorylation,GO:0002768~immune response-regulating cell surface receptor signaling pathway,GO:0006461~protein complex assembly,GO:0006874~cellular calcium ion homeostasis,GO:0006954~inflammatory response,GO:0006955~immune response,GO:0007275~multicellular organism development,GO:0030168~platelet activation,GO:0030890~positive regulation of B cell proliferation,GO:0032496~response to lipopolysaccharide,GO:0032735~positive regulation of interleukin-12 production,GO:0033209~tumor necrosis factor-mediated signaling pathway,GO:0042100~B cell proliferation,GO:0042113~B cell activation,GO:0042127~regulation of cell proliferation,GO:0042511~positive regulation of tyrosine phosphorylation of Stat1 protein,GO:0042832~defense response to protozoan,GO:0043123~positive regulation of I-kappaB kinase/NF-kappaB signaling,GO:0043406~positive regulation of MAP kinase activity,GO:0043491~protein kinase B signaling,GO:0043547~positive regulation of GTPase activity,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0048304~positive regulation of isotype switching to IgG isotypes,GO:0050776~regulation of immune response,GO:0051023~regulation of immunoglobulin secretion,GO:0051092~positive regulation of NF-kappaB transcription factor activity,GO:0051607~defense response to virus,GO:0071222~cellular response to lipopolysaccharide,GO:0071260~cellular response to mechanical stimulus,GO:0090037~positive regulation of protein kinase C signaling,GO:0097190~apoptotic signaling pathway,GO:2000353~positive regulation of endothelial cell apoptotic process,	GO:0005615~extracellular space,GO:0005737~cytoplasm,GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0009897~external side of plasma membrane,GO:0009986~cell surface,GO:0016021~integral component of membrane,GO:0035631~CD40 receptor complex,GO:0043231~intracellular membrane-bounded organelle,GO:0070062~extracellular exosome,	GO:0003823~antigen binding,GO:0004871~signal transducer activity,GO:0004872~receptor activity,GO:0005031~tumor necrosis factor-activated receptor activity,GO:0005515~protein binding,GO:0019899~enzyme binding,GO:0031625~ubiquitin protein ligase binding,	hsa04060:Cytokine-cytokine receptor interaction,hsa04064:NF-kappa B signaling pathway,hsa04514:Cell adhesion molecules (CAMs),hsa04620:Toll-like receptor signaling pathway,hsa04672:Intestinal immune network for IgA production,hsa05144:Malaria,hsa05145:Toxoplasmosis,hsa05166:HTLV-I infection,hsa05169:Epstein-Barr virus infection,hsa05202:Transcriptional misregulation in cancer,hsa05310:Asthma,hsa05320:Autoimmune thyroid disease,hsa05322:Systemic lupus erythematosus,hsa05330:Allograft rejection,hsa05340:Primary immunodeficiency,hsa05416:Viral myocarditis,	606843~Immunodeficiency with hyper-IgM, type 3,	R-HSA-198933:R-HSA-198933,R-HSA-5668541:R-HSA-5668541,R-HSA-5676594:R-HSA-5676594,
TNFRSF10B	TNF receptor superfamily member 10b(TNFRSF10B)	Homo sapiens	GO:0006915~apoptotic process,GO:0006919~activation of cysteine-type endopeptidase activity involved in apoptotic process,GO:0006954~inflammatory response,GO:0006955~immune response,GO:0007165~signal transduction,GO:0007166~cell surface receptor signaling pathway,GO:0007250~activation of NF-kappaB-inducing kinase activity,GO:0007275~multicellular organism development,GO:0008625~extrinsic apoptotic signaling pathway via death domain receptors,GO:0032496~response to lipopolysaccharide,GO:0033209~tumor necrosis factor-mediated signaling pathway,GO:0034976~response to endoplasmic reticulum stress,GO:0042127~regulation of cell proliferation,GO:0042981~regulation of apoptotic process,GO:0043123~positive regulation of I-kappaB kinase/NF-kappaB signaling,GO:0070059~intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress,GO:0071260~cellular response to mechanical stimulus,GO:0097296~activation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway,GO:1902041~regulation of extrinsic apoptotic signaling pathway via death domain receptors,GO:1902042~negative regulation of extrinsic apoptotic signaling pathway via death domain receptors,	GO:0005622~intracellular,GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0009986~cell surface,GO:0016021~integral component of membrane,	GO:0004872~receptor activity,GO:0005031~tumor necrosis factor-activated receptor activity,GO:0005515~protein binding,GO:0045569~TRAIL binding,	hsa04060:Cytokine-cytokine receptor interaction,hsa04210:Apoptosis,hsa04650:Natural killer cell mediated cytotoxicity,hsa05162:Measles,hsa05164:Influenza A,	275355~Squamous cell carcinoma, head and neck,	R-HSA-140534:R-HSA-140534,R-HSA-3371378:R-HSA-3371378,R-HSA-5213460:R-HSA-5213460,R-HSA-5218900:R-HSA-5218900,R-HSA-69416:R-HSA-69416,R-HSA-75158:R-HSA-75158,
TNFRSF1A	TNF receptor superfamily member 1A(TNFRSF1A)	Homo sapiens	GO:0006693~prostaglandin metabolic process,GO:0006954~inflammatory response,GO:0006955~immune response,GO:0007165~signal transduction,GO:0007249~I-kappaB kinase/NF-kappaB signaling,GO:0008625~extrinsic apoptotic signaling pathway via death domain receptors,GO:0008630~intrinsic apoptotic signaling pathway in response to DNA damage,GO:0010803~regulation of tumor necrosis factor-mediated signaling pathway,GO:0016032~viral process,GO:0019221~cytokine-mediated signaling pathway,GO:0032496~response to lipopolysaccharide,GO:0033209~tumor necrosis factor-mediated signaling pathway,GO:0042127~regulation of cell proliferation,GO:0042511~positive regulation of tyrosine phosphorylation of Stat1 protein,GO:0042742~defense response to bacterium,GO:0042981~regulation of apoptotic process,GO:0043123~positive regulation of I-kappaB kinase/NF-kappaB signaling,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0050728~negative regulation of inflammatory response,GO:0050729~positive regulation of inflammatory response,GO:0071260~cellular response to mechanical stimulus,GO:0071550~death-inducing signaling complex assembly,GO:0090002~establishment of protein localization to plasma membrane,GO:1903140~regulation of establishment of endothelial barrier,GO:2000304~positive regulation of ceramide biosynthetic process,	GO:0000139~Golgi membrane,GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0005739~mitochondrion,GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0009986~cell surface,GO:0016021~integral component of membrane,GO:0043235~receptor complex,GO:0045121~membrane raft,	GO:0005031~tumor necrosis factor-activated receptor activity,GO:0005515~protein binding,GO:0043120~tumor necrosis factor binding,	hsa04010:MAPK signaling pathway,hsa04060:Cytokine-cytokine receptor interaction,hsa04064:NF-kappa B signaling pathway,hsa04071:Sphingolipid signaling pathway,hsa04210:Apoptosis,hsa04380:Osteoclast differentiation,hsa04668:TNF signaling pathway,hsa04920:Adipocytokine signaling pathway,hsa04931:Insulin resistance,hsa04932:Non-alcoholic fatty liver disease (NAFLD),hsa05010:Alzheimer's disease,hsa05014:Amyotrophic lateral sclerosis (ALS),hsa05142:Chagas disease (American trypanosomiasis),hsa05145:Toxoplasmosis,hsa05152:Tuberculosis,hsa05160:Hepatitis C,hsa05164:Influenza A,hsa05166:HTLV-I infection,hsa05168:Herpes simplex infection,	142680~Periodic fever, familial,614810~Multiple sclerosis, susceptibility to, 5,	R-HSA-5357786:R-HSA-5357786,R-HSA-5357905:R-HSA-5357905,R-HSA-5357956:R-HSA-5357956,R-HSA-5626978:R-HSA-5626978,R-HSA-5669034:R-HSA-5669034,R-HSA-75893:R-HSA-75893,
F3	coagulation factor III, tissue factor(F3)	Homo sapiens	GO:0001938~positive regulation of endothelial cell proliferation,GO:0002541~activation of plasma proteins involved in acute inflammatory response,GO:0002543~activation of blood coagulation via clotting cascade,GO:0006919~activation of cysteine-type endopeptidase activity involved in apoptotic process,GO:0007596~blood coagulation,GO:0007598~blood coagulation, extrinsic pathway,GO:0010641~positive regulation of platelet-derived growth factor receptor signaling pathway,GO:0016485~protein processing,GO:0019221~cytokine-mediated signaling pathway,GO:0030335~positive regulation of cell migration,GO:0045766~positive regulation of angiogenesis,GO:0050927~positive regulation of positive chemotaxis,GO:0051897~positive regulation of protein kinase B signaling,	GO:0005615~extracellular space,GO:0005886~plasma membrane,GO:0009986~cell surface,GO:0016021~integral component of membrane,GO:0031012~extracellular matrix,GO:0031233~intrinsic component of external side of plasma membrane,GO:0070062~extracellular exosome,GO:1905286~serine-type peptidase complex,	GO:0002020~protease binding,GO:0004252~serine-type endopeptidase activity,GO:0004896~cytokine receptor activity,GO:0005515~protein binding,GO:0005543~phospholipid binding,	hsa04610:Complement and coagulation cascades,		R-HSA-140834:R-HSA-140834,
CSTB	cystatin B(CSTB)	Homo sapiens	GO:0008344~adult locomotory behavior,GO:0010466~negative regulation of peptidase activity,GO:0010951~negative regulation of endopeptidase activity,GO:0045861~negative regulation of proteolysis,	GO:0005615~extracellular space,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0070062~extracellular exosome,	GO:0002020~protease binding,GO:0004866~endopeptidase inhibitor activity,GO:0004869~cysteine-type endopeptidase inhibitor activity,GO:0044822~poly(A) RNA binding,		254800~Epilepsy, progressive myoclonic 1A (Unverricht and Lundborg),
FABP4	fatty acid binding protein 4(FABP4)	Homo sapiens	GO:0001816~cytokine production,GO:0006469~negative regulation of protein kinase activity,GO:0006810~transport,GO:0019433~triglyceride catabolic process,GO:0042632~cholesterol homeostasis,GO:0045892~negative regulation of transcription, DNA-templated,GO:0050727~regulation of inflammatory response,GO:0050729~positive regulation of inflammatory response,GO:0050872~white fat cell differentiation,GO:0050873~brown fat cell differentiation,GO:0071285~cellular response to lithium ion,GO:0071356~cellular response to tumor necrosis factor,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005811~lipid particle,GO:0005829~cytosol,GO:0070062~extracellular exosome,	GO:0005215~transporter activity,GO:0005504~fatty acid binding,	hsa03320:PPAR signaling pathway,hsa04923:Regulation of lipolysis in adipocytes,		R-HSA-163560:R-HSA-163560,R-HSA-381340:R-HSA-381340,
HGF	hepatocyte growth factor(HGF)	Homo sapiens	GO:0000187~activation of MAPK activity,GO:0000902~cell morphogenesis,GO:0001837~epithelial to mesenchymal transition,GO:0001889~liver development,GO:0002576~platelet degranulation,GO:0006508~proteolysis,GO:0007067~mitotic nuclear division,GO:0008284~positive regulation of cell proliferation,GO:0010507~negative regulation of autophagy,GO:0014068~positive regulation of phosphatidylinositol 3-kinase signaling,GO:0030212~hyaluronan metabolic process,GO:0030335~positive regulation of cell migration,GO:0031100~organ regeneration,GO:0031643~positive regulation of myelination,GO:0032715~negative regulation of interleukin-6 production,GO:0032733~positive regulation of interleukin-10 production,GO:0033137~negative regulation of peptidyl-serine phosphorylation,GO:0035729~cellular response to hepatocyte growth factor stimulus,GO:0043154~negative regulation of cysteine-type endopeptidase activity involved in apoptotic process,GO:0045669~positive regulation of osteoblast differentiation,GO:0045766~positive regulation of angiogenesis,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0048012~hepatocyte growth factor receptor signaling pathway,GO:0050728~negative regulation of inflammatory response,GO:0050731~positive regulation of peptidyl-tyrosine phosphorylation,GO:0050918~positive chemotaxis,GO:0051450~myoblast proliferation,GO:0060326~cell chemotaxis,GO:0060665~regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling,GO:0070572~positive regulation of neuron projection regeneration,GO:0090201~negative regulation of release of cytochrome c from mitochondria,GO:1900744~regulation of p38MAPK cascade,GO:1901299~negative regulation of hydrogen peroxide-mediated programmed cell death,GO:1902042~negative regulation of extrinsic apoptotic signaling pathway via death domain receptors,GO:1902947~regulation of tau-protein kinase activity,GO:2000573~positive regulation of DNA biosynthetic process,	GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0016020~membrane,GO:0031093~platelet alpha granule lumen,	GO:0004252~serine-type endopeptidase activity,GO:0005515~protein binding,GO:0008083~growth factor activity,GO:0042056~chemoattractant activity,GO:0042802~identical protein binding,GO:0046982~protein heterodimerization activity,	hsa04014:Ras signaling pathway,hsa04015:Rap1 signaling pathway,hsa04151:PI3K-Akt signaling pathway,hsa04510:Focal adhesion,hsa05144:Malaria,hsa05200:Pathways in cancer,hsa05205:Proteoglycans in cancer,hsa05211:Renal cell carcinoma,hsa05218:Melanoma,	608265~Deafness, autosomal recessive 39,	R-HSA-114608:R-HSA-114608,R-HSA-1266695:R-HSA-1266695,
IL10RA	interleukin 10 receptor subunit alpha(IL10RA)	Homo sapiens	GO:0019221~cytokine-mediated signaling pathway,GO:0032496~response to lipopolysaccharide,GO:0050807~regulation of synapse organization,	GO:0005886~plasma membrane,GO:0016021~integral component of membrane,	GO:0004871~signal transducer activity,GO:0004872~receptor activity,GO:0004920~interleukin-10 receptor activity,GO:0005515~protein binding,GO:0019969~interleukin-10 binding,	hsa04060:Cytokine-cytokine receptor interaction,hsa04630:Jak-STAT signaling pathway,hsa05145:Toxoplasmosis,hsa05152:Tuberculosis,	613148~Inflammatory bowel disease 28, early onset, autosomal recessive,
MMP1	matrix metallopeptidase 1(MMP1)	Homo sapiens	GO:0006508~proteolysis,GO:0016032~viral process,GO:0022617~extracellular matrix disassembly,GO:0030574~collagen catabolic process,GO:0032461~positive regulation of protein oligomerization,GO:0044267~cellular protein metabolic process,GO:0050900~leukocyte migration,	GO:0005576~extracellular region,GO:0005578~proteinaceous extracellular matrix,GO:0005581~collagen trimer,GO:0031012~extracellular matrix,	GO:0004175~endopeptidase activity,GO:0004222~metalloendopeptidase activity,GO:0004252~serine-type endopeptidase activity,GO:0005509~calcium ion binding,GO:0008270~zinc ion binding,	hsa03320:PPAR signaling pathway,hsa05200:Pathways in cancer,hsa05219:Bladder cancer,hsa05323:Rheumatoid arthritis,	226600~Epidermolysis bullosa dystrophica, autosomal recessive, modifier of,606963~COPD, rate of decline of lung function in,	R-HSA-1442490:R-HSA-1442490,R-HSA-1474228:R-HSA-1474228,R-HSA-1592389:R-HSA-1592389,R-HSA-210991:R-HSA-210991,R-HSA-381426:R-HSA-381426,
PLAT	plasminogen activator, tissue type(PLAT)	Homo sapiens	GO:0001666~response to hypoxia,GO:0006464~cellular protein modification process,GO:0006508~proteolysis,GO:0007596~blood coagulation,GO:0014909~smooth muscle cell migration,GO:0031639~plasminogen activation,GO:0042730~fibrinolysis,GO:0045861~negative regulation of proteolysis,GO:0048008~platelet-derived growth factor receptor signaling pathway,	GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0005737~cytoplasm,GO:0009986~cell surface,GO:0030141~secretory granule,GO:0031012~extracellular matrix,GO:0045177~apical part of cell,GO:0070062~extracellular exosome,	GO:0001948~glycoprotein binding,GO:0004252~serine-type endopeptidase activity,GO:0005102~receptor binding,GO:0005515~protein binding,GO:0051219~phosphoprotein binding,	hsa04610:Complement and coagulation cascades,hsa05202:Transcriptional misregulation in cancer,	612348~Hyperfibrinolysis, familial, due to increased release of PLAT,612348~Thrombophilia, familial, due to decreased release of PLAT,	R-HSA-186797:R-HSA-186797,R-HSA-75205:R-HSA-75205,
RNASE3	ribonuclease A family member 3(RNASE3)	Homo sapiens	GO:0002227~innate immune response in mucosa,GO:0006401~RNA catabolic process,GO:0019731~antibacterial humoral response,GO:0050830~defense response to Gram-positive bacterium,GO:0090501~RNA phosphodiester bond hydrolysis,	GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0070062~extracellular exosome,	GO:0003676~nucleic acid binding,GO:0004519~endonuclease activity,GO:0004540~ribonuclease activity,	hsa05310:Asthma,
SPON1	spondin 1(SPON1)	Homo sapiens	GO:0007155~cell adhesion,GO:0036066~protein O-linked fucosylation,	GO:0005578~proteinaceous extracellular matrix,GO:0005615~extracellular space,GO:0005788~endoplasmic reticulum lumen,GO:0031012~extracellular matrix,	GO:0005515~protein binding,GO:0046872~metal ion binding,			R-HSA-5173214:R-HSA-5173214,